The Human Microbiome in Immune-Mediated Diseases

NCT02394964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-12-21

No results posted yet for this study

Summary

The immune system is influenced by the commensal microbes that live in the gut and on the skin. This study aims to characterize the microbiota of subjects with autoimmune disease in order to determine whether certain microbial species may cause or worsen immune-mediated diseases

Conditions

Interventions

OTHER

Sample Collection

Sample collection of blood, stool, and buccal and skin swab samples will be collected at baseline, week 4, and week 8

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Arthritis Foundation

    collaborator OTHER
  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • Yale University

    lead OTHER

Principal Investigators

  • Martin Kriegel, MD, PhD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02394964 on ClinicalTrials.gov